Fsv7
Suite 105, US · Founded 2020 · Delaware corporation
Find your way into Fsv7
Sign up to see every warm intro you have to Fsv7
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Fsv7 team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
MP
Matthew P. PandoNamed on SEC filing
PO
Philip OettingerNamed on SEC filing
KA
K. Angela MacfarlaneNamed on SEC filing
FB
Florian BrandNamed on SEC filing
RB
Ryan BarrettNamed on SEC filing
Reported raises · per SEC filings
Form D private placements$6.6M disclosed across 1 round · 2020
▶$6.6MraisedNov 2020 · 55 investors · Other Health CareRule 506(b)
▶$6.6MraisedNov 2020 · 55 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Matthew P. PandoExecutive Officer, Director
- Philip OettingerExecutive Officer
- K. Angela MacfarlaneDirector
- Florian BrandDirector
- Ryan BarrettDirector
- Offering amount
- $25.8M
- Amount sold
- $6.6M
- First sale
- Nov 2020
- Incorporated
- Corporation, Delaware, 2020
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has Fsv7 raised?
- Fsv7 has disclosed $6.6M raised across 1 round.
- Where is Fsv7 headquartered?
- Fsv7 is headquartered in Suite 105, US.